Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Chiral Resolution Technology. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patented hydrogen-bond resolution method for 2,3:6,7-dibenzobicyclo[3.3.1]octa-2,6-diene-4,8-dione. Achieves 99.9% ee and 55% total yield, offering superior cost efficiency for pharmaceutical manufacturing.
Patent CN103755582A details a novel direct resolution of DL-serine using cyclic phosphates. This report analyzes cost reduction in API manufacturing and supply chain reliability.
Patent CN114014874B reveals a breakthrough recycling method for Baloxavir intermediates, offering significant cost reduction and supply reliability for pharmaceutical manufacturers.
Patent CN107098866A offers cost-effective chiral resolution for Lesinurad intermediates, ensuring high purity and scalable supply chain solutions for global pharmaceutical manufacturing.
Patent CN104151249B details a high-purity chiral resolution method using camphorsulfonic acid, offering significant cost reduction and supply chain reliability for API manufacturing.
Patent CN103288801B reveals a novel method for high-purity esomeprazole sodium. Achieves superior chiral purity and eliminates titanium residue for reliable supply.